EP1399142A1 - USE OF ACETYL L-CARNITINE IN ASSOCIATION WITH THE BIOTIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 INSULIN-RESISTANT DIABETES MELLITUS